Singapore Institute of Advanced Medicine (SGX:9G2) entered into a medical service agreement with Icon SOC through its wholly-owned subsidiary, Proton Therapy, according to a filing with the Singapore Exchange on Wednesday.
Through this collaboration, Proton Therapy will provide proton therapy treatment to Icon's patients.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments